Indication
Microvascular Obstruction
1 clinical trial
2 products
Product
TemanogrelClinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Effect on Microvascular Obstruction of Temanogrel in Subjects Undergoing Percutaneous Coronary InterventionStatus: Terminated, Estimated PCD: 2022-08-23
Product
Placebo